Endocyte launches 4.5M-share offering

|By:, SA News Editor

Endocyte's (ECYT) offering would yield gross proceeds of $121.5M at current levels. Underwriters will have a 675K-share overallotment option. (PR)

The drug developer had $159M in cash/investments at the end of 2013, and no debt.

ECYT -0.7% AH